Εμφάνιση απλής εγγραφής

dc.creatorKoumbi, D.en
dc.creatorClement, J. C.en
dc.creatorSideratou, Z.en
dc.creatorYaouanc, J. J.en
dc.creatorLoukopoulos, D.en
dc.creatorKollia, P.en
dc.date.accessioned2015-11-23T10:36:06Z
dc.date.available2015-11-23T10:36:06Z
dc.date.issued2006
dc.identifier10.1016/j.bbagen.2006.03.005
dc.identifier.issn3044165
dc.identifier.urihttp://hdl.handle.net/11615/29789
dc.description.abstractA series of cationic liposomes known as cationic phosphonolipids (CPs) were evaluated as vehicles for in vitro gene transfer in K562 erythroleukemia cells and 5637 epithelial carcinoma cells. For each CP and target cell type examined, detailed analyses were performed to determine optimal transfection conditions (lipid/ DNA (+/-) charge ratio, amount of complexed episomal DNA, liposomal and lipoplex size, complexation medium and duration of complex-cell exposure time). Lipofection conditions were determined to be both cell- and lipid-type specific. Complexation medium critically affected transfection competence. The initial size of the liposome was not always predictive of lipofection potency. The lipid chemical composition had a strong impact upon lipofection efficiency; DOPE inclusion in the liposome formulations was found to affect the levels of transgene expression in a cell-dependent way. Notably, effective transgene expression was characterized by prominent plasmid nuclear incorporation. Human Aγ- and ε-globin transgene nuclear incorporation and expression in 5637 cells post GLB.391-mediated lipofection lends credence to its use as a vehicle of therapeutic transgene delivery. © 2006 Elsevier B.V. All rights reserved.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-33745246871&partnerID=40&md5=5b2f94b77ab396321c5772585a1433ef
dc.subjectCationic phosphonolipiden
dc.subjectGene transferen
dc.subjectLipofection conditionen
dc.subjectNuclear DNA incorporationen
dc.subjectTransgene expressionen
dc.subjectbeta galactosidaseen
dc.subjectcell nucleus DNAen
dc.subjectdioleylphosphatidylethanolamineen
dc.subjectdrug vehicleen
dc.subjectglb 391en
dc.subjectglb 43en
dc.subjectglb 73en
dc.subjectlipiden
dc.subjectlipofectamineen
dc.subjectliposomeen
dc.subjectluciferaseen
dc.subjectplasmid DNAen
dc.subjectunclassified drugen
dc.subjectarticleen
dc.subjectcell viabilityen
dc.subjectchemical compositionen
dc.subjectcomplex formationen
dc.subjectcontrolled studyen
dc.subjectDNA transfectionen
dc.subjectenzyme activityen
dc.subjectgene expressionen
dc.subjecthumanen
dc.subjecthuman cellen
dc.subjectincubation timeen
dc.subjectnonviral gene delivery systemen
dc.subjectparticle sizeen
dc.subjectphysical chemistryen
dc.subjectpriority journalen
dc.subjectprotein expressionen
dc.subjecttarget cellen
dc.subjecttransgeneen
dc.subjectCationsen
dc.subjectCell Line, Tumoren
dc.subjectHumansen
dc.subjectKineticsen
dc.subjectNucleic Acid Hybridizationen
dc.subjectPhospholipidsen
dc.subjectPlasmidsen
dc.subjectTransfectionen
dc.titleFactors mediating lipofection potency of a series of cationic phosphonolipids in human cell linesen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής